3-iodobenzylguanidine has been researched along with Compensatory Hyperinsulinemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anan, F; Eshima, N; Kakuma, T; Katsuragi, I; Masaki, T; Nakagawa, M; Saikawa, T; Shinohara, T; Takahashi, N; Tanaka, K; Yonemochi, H; Yoshimatsu, H | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Smoking is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System; Baroreflex; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Echocardiography; Female; Glucose; Heart Rate; Humans; Hyperinsulinism; Insulin Resistance; Male; Middle Aged; Norepinephrine; Risk Factors; Smoking | 2006 |